Provigil Related Published Studies
Well-designed clinical trials related to Provigil (Modafinil)
Modafinil for the treatment of fatigue in lung cancer: results of a
placebo-controlled, double-blind, randomized trial. [2014]
Modafinil augmentation therapy in unipolar and bipolar depression: a systematic
review and meta-analysis of randomized controlled trials. [2013]
Association of a deficit of arousal with fatigue in multiple sclerosis: effect of
modafinil. [2013]
Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a
randomized placebo-controlled cross-over study using pharmacological fMRI. [2013]
Armodafinil and modafinil in patients with excessive sleepiness associated with
shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and
comparing their concentration-effect relationships. [2012]
A placebo-controlled study of the modafinil added to risperidone in chronic
schizophrenia. [2012]
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. [2011.11]
A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. [2011.09.24]
Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. [2011.08]
Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial. [2011.07]
Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers. [2011.06]
Modafinil modulation of the default mode network. [2011.05]
Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. [2011.04]
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. [2011.04]
Effects of modafinil on emotional processing in first episode psychosis. [2011.03.01]
The safety of modafinil in combination with oral 9-tetrahydrocannabinol in humans. [2011.03]
Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C. [2011.02]
Acute modafinil effects on attention and inhibitory control in
methamphetamine-dependent humans. [2011]
Treatment of HIV-related fatigue with armodafinil: a placebo-controlled
randomized trial. [2011]
The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. [2010.12]
Effects of acute modafinil on cognition in trichotillomania. [2010.12]
Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. [2010.11.16]
Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. [2010.11]
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. [2010.11]
The effect of modafinil on cortical excitability in patients with narcolepsy: a randomized, placebo-controlled, crossover study. [2010.10]
Modafinil reverses hypoexcitability of the motor cortex in narcoleptic patients: a TMS study. [2010.10]
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. [2010.10]
Modafinil reduces microsleep during partial sleep deprivation in depressed patients. [2010.10]
Modulatory effects of modafinil on neural circuits regulating emotion and cognition. [2010.09]
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. [2010.08.24]
Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. [2010.08.01]
Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. [2010.08]
Effect of modafinil on impairments in neurobehavioral performance and learning associated with extended wakefulness and circadian misalignment. [2010.08]
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. [2010.07.27]
A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. [2010.07.15]
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. [2010.07]
Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. [2010.07]
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. [2010.06.01]
Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. [2010.06]
Modafinil for the treatment of multiple sclerosis-related fatigue. [2010.06]
Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study. [2010.06]
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. [2010.06]
A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence. [2010.05]
Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial. [2010.04.15]
Normalizing effects of modafinil on sleep in chronic cocaine users. [2010.03]
Modafinil for Parkinson's disease fatigue. [2010.03]
Modafinil reduces patient-reported tiredness after sedation/analgesia but does not improve patient psychomotor skills. [2010.02]
Modafinil does not serve as a reinforcer in cocaine abusers. [2010.01.15]
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010.01.15]
A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. [2010.01]
A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the
effect of modafinil on cancer-related fatigue among 631 patients receiving
chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology
Program Research base study. [2010]
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for
excessive sleepiness associated with jet lag disorder. [2010]
Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled
study. [2010]
Modafinil reduces microsleep during partial sleep deprivation in depressed
patients. [2010]
Modafinil effects during acute continuous positive airway pressure withdrawal: a
randomized crossover double-blind placebo-controlled trial. [2010]
A double-blind, placebo-controlled study of armodafinil for excessive sleepiness
in patients with treated obstructive sleep apnea and comorbid depression. [2010]
Modafinil for Parkinson's disease fatigue. [2010]
Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing
effects of methamphetamine in methamphetamine-dependent volunteers. [2010]
Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment. [2009.12.15]
Modafinil and zolpidem use by emergency medicine residents. [2009.12]
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. [2009.12]
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. [2009.12]
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. [2009.11]
Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. [2009.11]
Modafinil for the treatment of cocaine dependence. [2009.09.01]
Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). [2009.09]
A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. [2009.08.15]
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. [2009.08]
Modafinil as a potential motion sickness countermeasure. [2009.08]
Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. [2009.08]
The effect of modafinil on cognitive function in breast cancer survivors. [2009.06.15]
An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. [2009.04.01]
Efficacy and safety of modafinil in the treatment of cancer-related fatigue. [2009.04]
Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. [2009.03]
Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. [2009.03]
Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02.01]
Modafinil improves rapid shifts of attention. [2009.01]
Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. [2009.01]
An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects. [2008.12.20]
Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. [2008.12.12]
Effects of modafinil on simulator driving and self-assessment of driving following sleep deprivation. [2008.12]
Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: A critical review. [2008.11.18]
A placebo-controlled trial of modafinil for nicotine dependence. [2008.11.01]
Effects of modafinil and sleep loss on physiological parameters. [2008.11]
The effect of modafinil following acute CPAP withdrawal: a preliminary study. [2008.11]
Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. [2008.09]
Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. [2008.09]
Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects. [2008.08]
A placebo-controlled trial of modafinil for nicotine dependence. [2008.06.07]
Smoked cocaine self-administration is decreased by modafinil. [2008.03]
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. [2008.01.01]
A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. [2008.01]
Approved and investigational uses of modafinil : an evidence-based review. [2008]
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. [2007.12]
Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers. [2007.11]
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial. [2007.08.08]
Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. [2007.05.15]
A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia. [2007.05]
Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. [2007.01.15]
Does modafinil enhance activity of patients with myotonic dystrophy?: a double-blind placebo-controlled crossover study. [2007.01]
Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. [2006.12]
|